Scripps Tumorgraft Study

Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solid Tumor Malignancy or Hematologic Malignancy Hematologic Diseases Hematologic Neoplasms Hemic and Lymphatic Diseases Neoplasms Neoplasms by Site

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scripps Translational Science Institute

La Jolla, California, 92037, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 21 or over
diagnosis of a solid tumor malignancy, either resectable or metastatic or a hematologic malignancy
cognitively and emotionally able to give informed consent

Exclusion criteria

Under age 21
Not cognitively or emotionally able to give informed consent

Treatment and study plan

Primary outcomes

Facilitate the development of individualized tumorgraft models for many different types of cancer.

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Scripps Translational Science Institute

Other

Registry information

Important dates

Study start: 2012
Primary completion: 2014
Study completion: 2014
First posted: Nov 15, 2012
Registry last updated: Apr 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed